Detalles de la búsqueda
1.
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
Breast Cancer Res Treat
; 203(3): 497-509, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37938495
2.
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer.
BMC Cancer
; 24(1): 641, 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38789924
3.
Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy-a sub-analysis of the ALTTO study.
Br J Cancer
; 127(10): 1799-1807, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36050448
4.
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial.
BMC Cancer
; 21(1): 899, 2021 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34362344
5.
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer.
Curr Oncol Rep
; 23(5): 57, 2021 03 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33763756
6.
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial.
Br J Cancer
; 122(10): 1453-1460, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32203207
7.
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
Breast Cancer Res Treat
; 181(1): 199-209, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32246377
8.
Pertuzumab in HER2-positive early breast cancer: current use and perspectives.
Future Oncol
; 15(16): 1823-1843, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30938542
9.
Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center.
BMC Palliat Care
; 17(1): 13, 2018 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29301574
10.
The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC).
Acta Oncol
; 59(6): 723-725, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32167397
11.
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Nat Commun
; 14(1): 7018, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919269
12.
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.
J Clin Oncol
; 40(25): 2946-2956, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35763704
13.
Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial.
Ecancermedicalscience
; 16: 1379, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35702414
14.
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
Cancers (Basel)
; 14(11)2022 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681574
15.
The Exciting New Field of HER2-Low Breast Cancer Treatment.
Cancers (Basel)
; 13(5)2021 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33804398
16.
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience.
Breast
; 57: 86-94, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33799232
17.
Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials.
Eur J Cancer
; 148: 76-91, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740500
18.
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.
J Natl Cancer Inst
; 113(4): 462-470, 2021 04 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32750143
19.
Impact of HIV infection on baseline characteristics and survival of women with breast cancer.
AIDS
; 35(4): 605-618, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33394680
20.
Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials.
ESMO Open
; 5(1)2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32079624